TY - JOUR
T1 - Investigations on parotid gland recovery after IMRT in head and neck tumor patients
AU - Stock, Markus
AU - Dörr, Wolfgang
AU - Stromberger, Carmen
AU - Mock, Ulrike
AU - Koizar, Susanne
AU - Pötter, Richard
AU - Georg, Dietmar
PY - 2010/12
Y1 - 2010/12
N2 - PURPOSE: in recent years, the role of intensity-modulated radiotherapy (IMRT) for head and neck irradiation has increased. The main motivation is sparing the parotid gland and reduction of xerostomia. Generally, relative parotid volumes have been evaluated for treatment outcome and planning constraints, neglecting that absolute parotid volumes can vary significantly. The aim of the present study was to investigate changes in parotid gland function and set this in relation to absolute volumes.MATERIAL AND METHODS: 46 head and neck patients were treated by sparing at least the contralateral parotid gland. The mean dose to the contralateral gland was limited to 26 Gy. Parotid function was measured with scintigraphy before and at 3, 6, 9, and 12 months after radiotherapy. Gland recovery was correlated with absolute parotid gland volumes and mean dose. Finally the dose-effect relationship was investigated.RESULTS: the dose-volume histograms (DVHs) for the ipsi- and contralateral glands were significantly different. A correlation between absolute volumes receiving certain doses and the function loss after 3, 6, 9, and 12 months was found. The most significant correlation was found for the absolute volume that received at least 40 Gy (aV40). ED50 values of 23-38 Gy were observed for more than 50% function loss and and 52-68 Gy afor more than 75% function loss.CONCLUSION: the mean dose, aV40 or aV26, revealed similar correlations with the excretion rate and with recovery. Hence, also absolute volumes can be used for treatment planning. Longer recovery times show higher ED50 values indicating partial regeneration of gland functions.
AB - PURPOSE: in recent years, the role of intensity-modulated radiotherapy (IMRT) for head and neck irradiation has increased. The main motivation is sparing the parotid gland and reduction of xerostomia. Generally, relative parotid volumes have been evaluated for treatment outcome and planning constraints, neglecting that absolute parotid volumes can vary significantly. The aim of the present study was to investigate changes in parotid gland function and set this in relation to absolute volumes.MATERIAL AND METHODS: 46 head and neck patients were treated by sparing at least the contralateral parotid gland. The mean dose to the contralateral gland was limited to 26 Gy. Parotid function was measured with scintigraphy before and at 3, 6, 9, and 12 months after radiotherapy. Gland recovery was correlated with absolute parotid gland volumes and mean dose. Finally the dose-effect relationship was investigated.RESULTS: the dose-volume histograms (DVHs) for the ipsi- and contralateral glands were significantly different. A correlation between absolute volumes receiving certain doses and the function loss after 3, 6, 9, and 12 months was found. The most significant correlation was found for the absolute volume that received at least 40 Gy (aV40). ED50 values of 23-38 Gy were observed for more than 50% function loss and and 52-68 Gy afor more than 75% function loss.CONCLUSION: the mean dose, aV40 or aV26, revealed similar correlations with the excretion rate and with recovery. Hence, also absolute volumes can be used for treatment planning. Longer recovery times show higher ED50 values indicating partial regeneration of gland functions.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Chemotherapy, Adjuvant
KW - Combined Modality Therapy
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Male
KW - Middle Aged
KW - Mouth Neoplasms/drug therapy
KW - Neoadjuvant Therapy
KW - Neoplasm Staging
KW - Oropharyngeal Neoplasms/drug therapy
KW - Parotid Gland/diagnostic imaging
KW - Radiation Injuries/diagnostic imaging
KW - Radionuclide Imaging
KW - Radiotherapy Dosage
KW - Radiotherapy, Adjuvant
KW - Radiotherapy, Intensity-Modulated/adverse effects
KW - Salivation/radiation effects
KW - Sodium Pertechnetate Tc 99m
KW - Xerostomia/diagnostic imaging
KW - Young Adult
UR - http://www.scopus.com/inward/record.url?scp=79951681945&partnerID=8YFLogxK
U2 - 10.1007/s00066-010-2157-7
DO - 10.1007/s00066-010-2157-7
M3 - Journal article
C2 - 21136030
SN - 0179-7158
VL - 186
SP - 665
EP - 671
JO - Strahlentherapie und Onkologie
JF - Strahlentherapie und Onkologie
IS - 12
ER -